2 results  1 of 1 

1 Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
Juan Zhang, Dong-Ling Xu, Xiao-Bo Liu, Shao-jie Bi, Tong Zhao, Shu-Jian Sui, Xiao-Ping Ji, Qing-Hua Lu
Yonsei Med J.2016;57(2):321-327.   Published online 2016 January 28     DOI: http://dx.doi.org/10.3349/ymj.2016.57.2.321
      
2 Association of Lipoprotein-Associated Phospholipase A2 with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
Yu-Sheng Liu, Xiao-Bo Hu, Hong-Zhuan Li, Wei-Dong Jiang, Xin Wang, Hao Lin, Ai-Qiong Qin, Yong-Mei Wang, Tong Zhao, Zhao-Qiang Dong, Mei Zhang, Qing-Hua Lu
Yonsei Med J.2011;52(6):914-922.   Published online 2011 October 20     DOI: http://dx.doi.org/10.3349/ymj.2011.52.6.914
      

 1 of 1